Used in the synthesis of antiviral drugs, particularly as an intermediate in the production of protease inhibitors. Its structure supports selective binding in biological systems, making it valuable in developing treatments for viral infections such as hepatitis C. The compound's chiral centers and functional groups allow for precise interactions with enzyme active sites, enhancing drug efficacy and stability during development. Commonly employed in pharmaceutical research to optimize metabolic resistance and oral bioavailability in drug candidates.